Oncopeptides AB. Presents the New Anticancer Agent J1 at The American Society of Hematology Annual Meeting in Orlando, Florida

Oncopeptides today announced that preclinical results for J1 will be presented this weekend at the ASH annual meeting at a poster session on Saturday December 4th at 5:30PM.